Characteristics | COVID-19 (n = 96) | Influenza (n = 96) | p-value | ||
---|---|---|---|---|---|
Age, median (IQR) | 68 | (57–81) | 70 | (57–80) | 0.901 |
Male | 69 | (71.9%) | 54 | (56.3%) | 0.024* |
Body mass index, median (IQR)a | 27 | (24.5–30.7) | 26 | (23.4–29.5) | 0.204 |
Pregnancy | 1 | (1.0%) | 5 | (5.2%) | 0.211 |
Smoker status | |||||
Current | 4 | (4.2%) | 12 | (12.5%) | 0.033* |
Former | 27 | (28.1%) | 21 | (21.9%) | |
Never | 33 | (34.4%) | 21 | (21.9%) | |
Unknown | 32 | (33.3%) | 43 | (44.8%) | |
Nationality | |||||
Swiss | 79 | (82.3%) | 74 | (77.1%) | 0.370 |
Non-Swiss | 17 | (17.7%) | 22 | (22.9%) | |
Transfer from | |||||
Home | 82 | (85.4%) | 91 | (94.8%) | 0.030* |
Health care institutionb | 14 | (14.6%) | 5 | (5.2%) | |
Comorbidities | |||||
Charlson Comorbidity Index, median (IQR) | 1 | (0–2) | 2 | (0–3) | 0.027* |
Hypertension | 53 | (55.2%) | 48 | (50.0%) | 0.470 |
Chronic cardiovascular disease | 40 | (41.7%) | 50 | (52.1%) | 0.148 |
Chronic respiratory disease | 10 | (10.4%) | 20 | (20.8%) | 0.047* |
Chronic renal disease | 20 | (20.8%) | 34 | (35.4%) | 0.025* |
Chronic liver disease | 2 | (2.1%) | 9 | (9.4%) | 0.030* |
Diabetes | 28 | (29.2%) | 23 | (24.0%) | 0.414 |
Obesityc | 21 | (22.6%) | 19 | (24.7%) | 0.749 |
Oncological pathology | 8 | (8.3%) | 25 | (26.0%) | 0.001* |
Osteoporosis | 6 | (6.3%) | 6 | (6.3%) | 1.000 |
Rheumatologic disease, immunosuppressed | 5 | (5.2%) | 11 | (11.5%) | 0.235 |
Hematologic disease, immunosuppressed | 3 | (3.1%) | 4 | (4.2%) | 1.000 |
Solid organ transplant | 0 | 1 | (1.0%) | 1.000 |